Home/Filings/4/0001209191-23-035862
4//SEC Filing

Rubinstein Linda M 4

Accession 0001209191-23-035862

CIK 0001501756other

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 4:26 PM ET

Size

5.1 KB

Accession

0001209191-23-035862

Insider Transaction Report

Form 4
Period: 2023-06-07
Rubinstein Linda M
CHIEF FINANCIAL OFFICER
Transactions
  • Purchase

    Common Stock

    2023-06-07$1.45/sh+100,000$145,490100,000 total
Footnotes (1)
  • [F1]Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.38 to $1.53. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

Issuer

Adverum Biotechnologies, Inc.

CIK 0001501756

Entity typeother

Related Parties

1
  • filerCIK 0001321937

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:26 PM ET
Size
5.1 KB